Vallabh Janardhan
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$443KFederal grants as PI2 awards
13Patents grantedLatest Nov 25, 2025
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $443K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 1, 2018 | NSF | SBIR Phase I SBIR Phase I: Development of a textile-based retrievable stent for stroke that can be personalized to a patient's clot burden and retrieve long clots using torsion. | $222K | Insera Therapeutics Inc. |
| Jun 25, 2018 | NSF | SBIR Phase I SBIR Phase I: Development of a textile-based retrievable stent for stroke that can be personalized to a patient's clot burden and retrieve long clots using torsion. | $222K | Insera Therapeutics Inc. |
14 patents as inventor
- US 10251739Insera Therapeutics Inc.Apr 9, 2019
- US 10335260Insera Therapeutics Inc.Jul 2, 2019
- US 10342655Insera Therapeutics Inc.Jul 9, 2019
- US 10390926Insera Therapeutics Inc.Aug 27, 2019
- US 10463468Insera Therapeutics Inc.Nov 5, 2019
- US 10751159Insera Therapeutics Inc.Aug 25, 2020
- US 11298144Insera Therapeutics Inc.Apr 12, 2022
- US 12478390Insera Therapeutics Inc.Nov 25, 2025
- US D847864Insera Therapeutics Inc.May 7, 2019
- US D847865Insera Therapeutics Inc.May 7, 2019
- US D847866Insera Therapeutics Inc.May 7, 2019
- US D850490Insera Therapeutics Inc.Jun 4, 2019
- US D896847Insera Therapeutics Inc.Sep 22, 2020
- US Insera Therapeutics Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#2,956
Awards as PI#1,503
Patents#4
Companies
- Insera Therapeutics Inc.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.